Article
Impact of the CYP2C19 Gene Polymorphism on Clopidogrel Personalized Drug Regimen and the Clinical Outcomes.
Clinical laboratory - 1 Sept 2016
Chen Keguang, Zhang Rui, Liu Huanjun, Guo Xi, Li Pingli, Liu Xuehong
Abstract excerpt
BACKGROUND: Although the relationship between CYP2C19 genotype and clopidogrel metabolism has been studied clearly, we have not seen the report that clopidogrel was administered at a dose adjusted based on genotyping. The two main polymorphism loci of CYP2C19 gene were detected by the CYP2C19 genetic testing. ADP platelet aggregation technology was used to investigate the correlation between clinical effect and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
